Loti 27 Rituximab Biosimilar ose origjinator
| Contracted Institution | Ministry of Health | ||||||||||
| Tenderer Institution | Ministry of Health | ||||||||||
| Tender object | Loti 27 Rituximab Biosimilar ose origjinator | ||||||||||
| Reference No. | REF-25127-04-14-2022 | ||||||||||
| CPV Code | |||||||||||
| Estimated / Ceiling Value ALL without VAT | 11 842 417,00 | ||||||||||
| Type of Contract | |||||||||||
| Procurement Method | Open Procedure above the high monetary limit | ||||||||||
| Stage Procedure | Announced the Winner | ||||||||||
| Tender Publication Date | 19-04-2022 | ||||||||||
| Last date of Submitted Documents | 19-05-2022 | ||||||||||
| Tender Held Date | 19-05-2022 | ||||||||||
| No. of Bidders | 2 | ||||||||||
| Bidders |
1.BOE EDNA - FARMA shpk & DELTA PHARMA - AL shpk 2. MEGAPHARMA shpk |
||||||||||
| Successful Bidder /Supplier / Provider |
|
||||||||||
| The winning bid ALL without vat | 11 132 000,00 | ||||||||||
| Bidder Announcement date | 27-06-2022 | ||||||||||
| Award and Contract Amount ALL with VAT | |||||||||||
| Contract date | |||||||||||
| Planned Milestones of Contract / Start and End Date | Kontratat mund të lidhen nga AK përfituese brenda afatit 24 muaj nga data e nënshkrimit të MK nga palët, për sejcilin lot | ||||||||||
| Renewal Contract Additional Value (ALL with VAT) |
|
||||||||||
| Appeals |
Eshte skualifikuar operatori ekonomik i meposhtem: - MEGAPHARMA shpk per arsye: -nuk ka paraqitur ofertë ekonomike për këtë lot. |
||||||||||
| Cancellation reason | |||||||||||
| Additions | |||||||||||
| Transaction / Actual Spending |
|
||||||||||
| Public Announcement Bulletin |
|